منابع مشابه
[Uveal effusion induced by escitalopram].
CASE REPORT A 73 year-old woman with depression treated with escitalopram developed acute secondary angle closure glaucoma related to uveal effusion after duplicating the drug dose 3 days before. She evolved favorably once the antidepressant treatment was suspended and a new treatment with topical hypotensive therapy and oral prednisone was used. DISCUSSION The uveal effusion syndrome associa...
متن کاملEscitalopram-induced subclinical hypothyroidism. A case report.
Several conditions and drugs induce subclinical hypothyroidism. We report a case of asymptomatic and reversible subclinical hypothyroidism in a 48-year old woman with minor depressive disorder receiving therapy with escitalopram 20 mg daily for six months.
متن کاملSSRI Antidepressants: Focus on Escitalopram by
Escitalopram is an antidepressant from the class called Selective Serotonin Reuptake Inhibitors (SSRI’s). SSRI’s were among the first pharmaceutical products commercialized as single enantiomers following a 1992 United States Food and Drug Administration (FDA) Policy Statement. The directive required a thorough investigation of the biological and toxicological properties of single enantiomers. ...
متن کاملPS108. Characteristics of escitalopram discontinuation syndrome
s | 37 clinicians to better understand and choose better treatment options for these populations.
متن کاملClinical and ECG effects of escitalopram overdose.
STUDY OBJECTIVE We investigate the clinical effects of escitalopram overdose and determine the risk of QT prolongation and serotonin toxicity. METHODS A review of escitalopram overdoses to a clinical toxicology unit was undertaken. Patient demographics, details of the ingestion, clinical effects, including evidence of serotonin toxicity, complications (arrhythmias and seizures), ICU admission...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: pharma-kritik
سال: 2003
ISSN: 1010-5409
DOI: 10.37667/pk.2003.72